What is the current price of Cellframe?
The current price of Cellframe is $0.06894 with a 1.63% change in the last 24 hours.
Supply and ATH/ATL data provided by CoinGecko
Hyperliquid perpetuals only. One snapshot every 5 minutes, up to 20 returned price levels per side. Liquidity beyond those levels is unknown. This is not a liquidation heatmap or a fill estimate.
Loading recorded snapshots…
Prices and notionals are USD-equivalent venue units, with USDC collateral. No currency conversion is applied. Notional = venue price × base-asset size. Contract specifications
Derivatives and mapped ecosystem data, with source timings and coverage.
Cellframe is an open-source platform for building and bridging blockchains and services, secured by post-quantum cryptography. Its pitch is that today's common signature schemes could one day be broken by quantum computers, so Cellframe builds quantum-resistant signatures into the base protocol and lets the algorithm be swapped later without a fork. CELL is the network's native token, used for staking, validator participation and value transfer, and it also exists as ERC-20 and BEP-20 tokens on Ethereum and BNB Chain.
The project describes itself as a Layer 0 style protocol: a base layer that coordinates many subchains, rather than a single smart contract chain.
The whitepaper is published under the copyright of Demlabs Inc, the company behind the Cellframe code, which is hosted on Demlabs' own GitLab. Dmitry Gerasimov appears on the official site as a prominent figure in project communications. A full founding team and founding date are not documented on the pages reviewed, so treat those details as unconfirmed.
Cellframe uses what it calls dual-layer sharding:
ZeroChain The root layer stores inter-cell communication and administrative data. Per the whitepaper it uses Proof-of-Genesis, a modified Proof-of-Authority in which each block must be signed by half plus one of the root keys.
Cells and subchains Cells are shards with their own base chains. The first layer lets builders create custom subchains and tokens; the second groups them into Cells that talk to each other peer to peer without a central hub. Cells can use Proof-of-Stake or DPoS/PoA variants chosen by the chain's initiators.
Instead of general smart contracts, Cellframe relies heavily on conditional transactions, which the whitepaper says can replace "90% of typical smart contract operations" with lower cost and a smaller attack surface. There is no mining. The core is written in plain C, which the team says lets services run on hardware from servers down to small devices.
The whitepaper sets a 2025 reward pool of 2 million CELL, split into 1.6 million for validator rewards and 0.4 million for staking rewards. Of the staking share, 0.144 million goes to solo staking, 0.16 million to Uniswap pairs and 0.096 million to PancakeSwap pairs. Validators additionally earn service and transaction fees.
Two design choices stand out. First, post-quantum signatures are native rather than bolted on: the whitepaper lists CRYSTALS-Dilithium as the default, with other schemes such as Picnic supported, and every key carries a 2-byte algorithm ID so up to 65,536 algorithms can be addressed. Second, the service-oriented model treats the blockchain as a platform for paid network services (such as VPN and exchange services) rather than only for tokens and contracts.
Polkadot and Cosmos also coordinate many chains, but neither uses post-quantum signatures by default. QANplatform shares the quantum-resistance focus but centres on smart contracts, while Cellframe leans on conditional transactions and C-based services. Quant targets interoperability for enterprises without running its own sharded chain.
Security rests on three layers: post-quantum signature algorithms at the cryptographic level, Proof-of-Genesis on ZeroChain, and Proof-of-Stake (or chain-chosen variants) inside Cells. The ERC-20 and BEP-20 versions of CELL are secured by Ethereum and BNB Chain respectively, and the bridge between them is an additional trust point. No independent audit report was found on the pages reviewed.
Cellframe is one of the few networks that made post-quantum cryptography a first-class design goal from the start, and its swappable-algorithm approach is a practical answer to the question of how blockchains migrate when cryptography ages.
CELL trades on decentralized exchanges on Ethereum (Uniswap) and BNB Chain (PancakeSwap), which the official site names, and on centralized exchanges; the site lists Gate.io and MEXC among them. Check the contract address before trading.
ERC-20 CELL (0x26c8afbbfe1ebaca03c2bb082e69d0476bffe099, Etherscan) and BEP-20 CELL (0xd98438889ae7364c7e2a3540547fad042fb24642, BscScan) can be held in MetaMask, Trust Wallet or hardware wallets. Native CELL for staking needs a Cellframe-compatible wallet; see the wiki for the current wallet software.
Official links: Website · Whitepaper
Track Cellframe live price, chart, market cap, and volume in real time. Practice mock trading and demo trading for Cellframe on CoinRithm before using real money.
Use a crypto paper trading account to demo trade Cellframe with real-time prices, AI trade feedback, and trading leagues. Test strategies, learn risk management, and build confidence before trading Cellframe with real money.
Read the complete paper trading guideThe current price of Cellframe is $0.06894 with a 1.63% change in the last 24 hours.
The daily trading volume is $75,178.62 representing a 18.86% change in the past 24 hours.
The market capitalization of Cellframe is $2,562,500, ranking #835 globally.
The fully diluted valuation (FDV) of Cellframe is $2,601,451, calculated assuming the total supply of 37,735,000 CELL is in circulation.
Circulating: 37,170,000. Total: 37,735,000. Max: N/A.
In the last 24 hours, Cellframe traded between a low of $0.06436 and a high of $0.07026.
CELL/USDTTether USDT0.06894 USDT
Muse Charm is Meta's palm-sized gadget for talking to its Muse AI agent on the go. It has cameras, a fingerprint sensor, and its own cell connection.
YZi Labs is investing in Renewal Bio's groundbreaking stem cell technology to solve the global organ transplant shortage through regenerative medicine.
